Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Hari Gorla

  • Home
  • Author: Hari Gorla

Hyundai aims to re-energize commercial vehicle market with hydrogen fuel cell technology, says GlobalData

Following the news that South Korean automaker Hyundai plans to offer hydrogen fuel cell versions of all its commercial vehicles by 2028; Bakar Sadik Agwan, Senior Automotive Consulting Analyst at GlobalData, a leading data and analytics company, offers his view: “Hyundai’s announcement to feature fuel cell electric or battery electric powertrains, as well as the […]
Read more

Flipkart prepares ground for IPO, hires for those with listing experience, observes GlobalData

Flipkart’s plans for an IPO in 2021 could well be on track. The India-based e-commerce giant’s recent listings suggest that the company is hiring for mid-level and senior-level positions aimed for IPO preparedness, among other key responsibilities. The company is posting jobs to staff its financial planning and analysis (FPA) and the consolidating and reporting […]
Read more

UltraFan engine another example of why Rolls-Royce is considered by GlobalData as a significant player in the climate change theme

Rolls-Royce’s gas-powered turbine demonstrates how the company is embracing decarbonization strategies and its willingness to embrace more climate-friendly solutions in pursuit of profit, according to GlobalData. The leading data and analytics company notes that Rolls-Royce took a significant hit to profits during the pandemic, accruing significant debt due to its exposure to the civil aerospace […]
Read more

Ono Pharma Braftovi approval in South Korea will strengthen oncology portfolio but with limited sales potential, says GlobalData

Ono Pharmaceutical’s Braftovi (encorafenib) was recently approved in South Korea as a combination therapy with cetuximab to treat BRAF V600E mutant in previously treated metastatic colorectal cancer (mCRC) patients. However, the limited potential population of BRAF V600E mCRC patients in South Korea is expected to impact its overall sales potential, says GlobalData, a leading data […]
Read more

Vaccine tourism is a double-edged sword

Vaccine tourism, where tourist hotspots are now offering COVID-19 vaccinations on holiday to attract visitors, is a double-edged sword as, while it could assist travel’s restart, it also raises the question of vaccine equity as it will further increase the divide between the wealthy and less privileged, says GlobalData, a leading data and analytics company. […]
Read more

McDonald’s McPlant burger will see success with UK’s non-meat eaters despite late market entry, says GlobalData

Following today’s news (9 September) that McDonald’s will be trialling a plant-based burger in some of its UK stores; Ramsey Baghdadi, Consumer Analyst at GlobalData, a leading data and analytics company, offers his view: “The McPlant burger will join the list of existing plant-based products in the UK foodservice sector, such as the growing alternative […]
Read more

Burger King’s celebrity endorsements will promote its natural rebrand to 38% of US population that demand healthier foods

Following today’s news that Burger King will release a celebrity endorsed meal range, ‘Keeping it Real’, in line with its recent ban on 120 artificial ingredients; Carmen Bryan, Consumer Analyst at GlobalData, a leading data and analytics company, offers her view: “Burger King is hoping to cash in on the immense success that McDonald’s sponsored […]
Read more

Induction of MRSAM to significantly enhance Indian Air Force’s air and missile defense capability, says GlobalData

Following the news that Indian Air Force (IAF) has inducted the first Medium Range Surface to Air Missile (MRSAM) system; Tushar M, Defence Analyst at GlobalData, a leading data and analytics company, offers his view: “The addition of MRSAM is expected to augment the country’s aerial surveillance and air defense capabilities against a variety of […]
Read more

ObsEva’s Yselty provides promise in endometriosis drug market, says GlobalData

Endometriosis is an indication that needs new therapy options. The variety of symptoms across cases, non-specificity of symptoms, and overlap of symptomology with other conditions make it difficult to manage, with cases often being misdiagnosed. According to GlobalData’s Pharma Intelligence Center database, there are 46 pipeline drugs currently being developed for endometriosis worldwide*. The leading […]
Read more

Singapore deploys technology to drive its vision of achieving smart healthcare system, says GlobalData

Singapore aims to provide smart healthcare to people with the help of novel technologies, which is helping the country to withstand the impact of COVID-19 on its healthcare system, says GlobalData, a leading data and analytics company. GlobalData’s report, ‘CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Singapore’, reveals that the Singapore healthcare market is a […]
Read more

South Korea’s preferential drug pricing system can boost innovation in pharma research, says GlobalData

South Korea has recently decided to provide practical support to innovative pharmaceutical companies by revising the existing health insurance benefits system. The new system of preferential drug pricing, if designed effectively, can boost innovation in the country’s pharmaceutical research, says GlobalData, a leading data and analytics company. According to GlobalData, the pharmaceutical market in South […]
Read more

Interconnectivity key to powering smart hospitals

The idea of a smart hospital has been increasingly discussed in recent months due to a combination of new technologies such as the release of 5G networks and the COVID-19 pandemic highlighting the need for telehealth and other connected solutions. At its core, a smart hospital is an interconnected one, where patient health metrics, test […]
Read more
1 … 10 11 12 13 14 … 60